Literature DB >> 1926546

Hyperreactive malarial splenomegaly in pregnancy.

I Bates1.   

Abstract

Hyperreactive malarial splenomegaly (HMS) is common in many tropical areas and particularly affects women of reproductive age. It is associated with anaemia which can be debilitating in patients already compromised by anaemia due to poor nutrition and pregnancy. The course of the disorder in pregnancy is commonly punctuated by episodes of haemolytic anaemia which can be life-threatening to the mother and cause increased fetal morbidity and loss. Management of the chronic state consists of lifelong anti-malarial therapy supplemented by haematinics. Blood transfusions may be required to treat episodes of severe haemolysis.

Entities:  

Mesh:

Year:  1991        PMID: 1926546     DOI: 10.1177/004947559102100304

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  Early hyperreactive malarial splenomegaly and risk factors for evolution into the full-blown syndrome: a single-centre, retrospective, longitudinal study.

Authors:  Zeno Bisoffi; Stefania Leoni; Dora Buonfrate; Claudia Lodesani; Franklin Esoka Eseme; Geraldo Badona Monteiro; Stefania Marocco; Massimo Guerriero
Journal:  Malar J       Date:  2015-12-02       Impact factor: 2.979

2.  Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model.

Authors:  Norinne Lacerda-Queiroz; Nicolas Riteau; Richard T Eastman; Kevin W Bock; Marlene S Orandle; Ian N Moore; Alan Sher; Carole A Long; Dragana Jankovic; Xin-Zhuan Su
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

3.  Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine.

Authors:  Juthamas Jaroensuk; Nicole Stoesser; Mara L Leimanis; Podjanee Jittamala; Nicholas J White; Francois H Nosten; Rose McGready
Journal:  Am J Trop Med Hyg       Date:  2014-03-03       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.